CN102885304B - 一种增加骨密度的保健食品组合物及其制备方法 - Google Patents
一种增加骨密度的保健食品组合物及其制备方法 Download PDFInfo
- Publication number
- CN102885304B CN102885304B CN201210385998.2A CN201210385998A CN102885304B CN 102885304 B CN102885304 B CN 102885304B CN 201210385998 A CN201210385998 A CN 201210385998A CN 102885304 B CN102885304 B CN 102885304B
- Authority
- CN
- China
- Prior art keywords
- bone
- weight
- parts
- extract
- weight portion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000000988 bone and bone Anatomy 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 235000013402 health food Nutrition 0.000 title abstract description 11
- 239000002131 composite material Substances 0.000 title abstract 5
- 229910052500 inorganic mineral Inorganic materials 0.000 title abstract 2
- 239000011707 mineral Substances 0.000 title abstract 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N 2-Amino-2-Deoxy-Hexose Chemical compound NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims abstract description 28
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims abstract description 27
- 241000282985 Cervus Species 0.000 claims abstract description 27
- 229920001287 Chondroitin sulfate Polymers 0.000 claims abstract description 27
- 229940059329 chondroitin sulfate Drugs 0.000 claims abstract description 27
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims abstract description 9
- 229930003944 flavone Natural products 0.000 claims abstract description 9
- 150000002212 flavone derivatives Chemical class 0.000 claims abstract description 9
- 235000011949 flavones Nutrition 0.000 claims abstract description 9
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000008187 granular material Substances 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims description 38
- 235000018905 epimedium Nutrition 0.000 claims description 27
- 241000893536 Epimedium Species 0.000 claims description 25
- 239000011248 coating agent Substances 0.000 claims description 25
- 230000037182 bone density Effects 0.000 claims description 22
- 238000000576 coating method Methods 0.000 claims description 19
- 235000013305 food Nutrition 0.000 claims description 19
- 229920001353 Dextrin Polymers 0.000 claims description 12
- 239000004375 Dextrin Substances 0.000 claims description 12
- 239000002202 Polyethylene glycol Substances 0.000 claims description 12
- 235000019425 dextrin Nutrition 0.000 claims description 12
- 239000011812 mixed powder Substances 0.000 claims description 12
- 229920001223 polyethylene glycol Polymers 0.000 claims description 12
- 239000011122 softwood Substances 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- 239000003814 drug Substances 0.000 claims description 11
- 239000005025 cast polypropylene Substances 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 8
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 7
- DKHJWWRYTONYHB-UHFFFAOYSA-N CPP Chemical compound OC(=O)C(C)OC1=CC=C(Cl)C=C1 DKHJWWRYTONYHB-UHFFFAOYSA-N 0.000 claims description 6
- 229940036811 bone meal Drugs 0.000 claims description 6
- 239000002374 bone meal Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000007873 sieving Methods 0.000 claims description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 17
- 239000011575 calcium Substances 0.000 abstract description 17
- 229910052791 calcium Inorganic materials 0.000 abstract description 17
- 210000003734 kidney Anatomy 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 9
- 239000000463 material Substances 0.000 abstract description 8
- 210000004185 liver Anatomy 0.000 abstract description 7
- 239000000843 powder Substances 0.000 abstract description 7
- 210000003205 muscle Anatomy 0.000 abstract description 5
- 238000005728 strengthening Methods 0.000 abstract description 5
- 238000005516 engineering process Methods 0.000 abstract description 4
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 230000007774 longterm Effects 0.000 abstract description 3
- 206010057178 Osteoarthropathies Diseases 0.000 abstract description 2
- 239000007902 hard capsule Substances 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 239000007901 soft capsule Substances 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 108010001441 Phosphopeptides Proteins 0.000 abstract 2
- 239000005018 casein Substances 0.000 abstract 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 abstract 2
- 235000021240 caseins Nutrition 0.000 abstract 2
- 241000427159 Achyranthes Species 0.000 abstract 1
- 241001116742 Drynaria Species 0.000 abstract 1
- 241001122767 Theaceae Species 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 description 13
- 238000000034 method Methods 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 9
- 208000001132 Osteoporosis Diseases 0.000 description 8
- 238000012360 testing method Methods 0.000 description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000037396 body weight Effects 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 210000000265 leukocyte Anatomy 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 241000700159 Rattus Species 0.000 description 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 208000010392 Bone Fractures Diseases 0.000 description 3
- 206010017076 Fracture Diseases 0.000 description 3
- 238000011047 acute toxicity test Methods 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 210000000845 cartilage Anatomy 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 235000012631 food intake Nutrition 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 231100000572 poisoning Toxicity 0.000 description 3
- 230000000607 poisoning effect Effects 0.000 description 3
- 108010048734 sclerotin Proteins 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000003442 weekly effect Effects 0.000 description 3
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 2
- 108010082126 Alanine transaminase Proteins 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 2
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 231100000460 acute oral toxicity Toxicity 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000002489 hematologic effect Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 210000002997 osteoclast Anatomy 0.000 description 2
- 210000004409 osteocyte Anatomy 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000007115 recruitment Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 235000020985 whole grains Nutrition 0.000 description 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 241001148782 Davallia Species 0.000 description 1
- 241000424773 Epimedium alpinum Species 0.000 description 1
- 241001016310 Epimedium grandiflorum Species 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000015091 medicinal tea Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000001582 osteoblastic effect Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 210000004417 patella Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000003161 proteinsynthetic effect Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210385998.2A CN102885304B (zh) | 2012-10-12 | 2012-10-12 | 一种增加骨密度的保健食品组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210385998.2A CN102885304B (zh) | 2012-10-12 | 2012-10-12 | 一种增加骨密度的保健食品组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102885304A CN102885304A (zh) | 2013-01-23 |
CN102885304B true CN102885304B (zh) | 2014-01-15 |
Family
ID=47529156
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210385998.2A Active CN102885304B (zh) | 2012-10-12 | 2012-10-12 | 一种增加骨密度的保健食品组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102885304B (zh) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103110744B (zh) * | 2013-03-20 | 2014-10-15 | 吉林华康食元生物科技有限公司 | 一种增加骨密度的中药保健制剂及其制备方法 |
CN104605226A (zh) * | 2015-01-05 | 2015-05-13 | 洛阳新春都生物制药有限公司 | 一种具有增加骨密度功能的保健品 |
CN104666581B (zh) * | 2015-02-06 | 2018-06-22 | 北京方中方科技有限公司 | 用于增强骨密度并提高免疫力的保健品及其制备 |
CN104799280A (zh) * | 2015-04-10 | 2015-07-29 | 山东安然纳米实业发展有限公司 | 一种具有增强免疫力、增加骨密度功能的保健食品 |
CN105380272A (zh) * | 2015-12-08 | 2016-03-09 | 哈药集团三精制药有限公司 | 一种增加骨密度片的制备方法 |
CN106880839B (zh) * | 2015-12-14 | 2021-07-13 | 吉林省东鳌鹿业集团有限公司 | 一种鹿骨片及其制备方法 |
CN106235311A (zh) * | 2016-07-28 | 2016-12-21 | 广州赛莱拉干细胞科技股份有限公司 | 一种促进骨骼系统健康的组合物及其应用 |
CN110115385A (zh) * | 2018-02-05 | 2019-08-13 | 常州英莱克斯生物工程有限公司 | 一种可增加骨密度的劲骨片及其生产方法 |
CN109170916A (zh) * | 2018-11-02 | 2019-01-11 | 丽睿客信息科技(北京)有限公司 | 一种强身健体食品组合物及其制备方法 |
CN109601880B (zh) * | 2018-12-10 | 2022-06-24 | 金木集团有限公司 | 一种增加骨密度的保健食品 |
CN113115953A (zh) * | 2019-12-31 | 2021-07-16 | 北京司晨扬帆国际管理咨询有限公司 | 一种增加骨密度保健食品及其制备方法 |
CN111068044B (zh) * | 2020-01-06 | 2022-03-08 | 新疆华圣元医药科技有限公司 | 一种具有增加骨密度作用的药物组合物及其制剂 |
CN112137087A (zh) * | 2020-09-22 | 2020-12-29 | 兰州大得利生物化学制药(厂)有限公司 | 一种壮骨补钙的组合物、保健品及其制备方法 |
CN115804451A (zh) * | 2022-11-25 | 2023-03-17 | 广州欣盛通健康管理科技有限公司 | 一种有益于骨密度增加的组合物及其在食品中的应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3542190B2 (ja) * | 1995-03-10 | 2004-07-14 | 明治乳業株式会社 | カルシウム−カゼインホスホペプチド調製物の製造方法、骨塩減少抑制食品及び骨塩減少抑制剤 |
CN100471507C (zh) * | 2006-08-16 | 2009-03-25 | 杜学域 | 一种治疗骨质疏松的中药制剂 |
CN101015682B (zh) * | 2007-02-01 | 2011-02-02 | 兰州奇正健康日用品有限公司 | 具有增加骨密度功能的药物组合物及制备和质量控制方法 |
CN101524415A (zh) * | 2008-09-11 | 2009-09-09 | 牛志刚 | 一种治疗骨质疏松的功能食品 |
CN101455704B (zh) * | 2008-12-31 | 2011-04-20 | 谢林 | 一种预防和治疗骨质疏松的中药组合物及其制备方法 |
CN102657842A (zh) * | 2012-05-17 | 2012-09-12 | 双飞人制药(中国)有限公司 | 一种具有增加骨密度功能的药物组合物及其应用 |
-
2012
- 2012-10-12 CN CN201210385998.2A patent/CN102885304B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN102885304A (zh) | 2013-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102885304B (zh) | 一种增加骨密度的保健食品组合物及其制备方法 | |
CN102885306A (zh) | 一种辅助降血脂的保健食品组合物及其制备方法 | |
CN102885309B (zh) | 一种祛黄褐斑的保健食品组合物及其制备方法 | |
CN106360310A (zh) | 一种降低餐后血糖的组合物及其应用 | |
CN101966222A (zh) | 一种具有壮骨功效的药物组合物、制剂及其制备方法 | |
CN108402460A (zh) | 一种增加骨密度的多功能食品组合物及其制备方法 | |
CN105412406A (zh) | 一种降低血液粘稠度的中药组合物及其制备方法 | |
CN106362020B (zh) | 一种具有改善通便作用的松花粉组合物及其制备方法 | |
CN105639620A (zh) | 一种增加骨密度的保健食品组合物及其制备方法 | |
CN103768434B (zh) | 一种提高蛋鸡产蛋率的中药及其制备方法 | |
CN109771578A (zh) | 防治糖尿病及并发症的组合物 | |
CN102106993B (zh) | 一种治疗脂肪肝的中药组合物及其制备方法 | |
CN104740088A (zh) | 一种用于减肥瘦身的复方组合物及其制备方法 | |
CN104026568A (zh) | 一种保健品组合物 | |
CN100394969C (zh) | 一种治疗骨质疏松症的中药复方制剂及其制备方法 | |
CN102885305A (zh) | 一种增强免疫力的保健食品组合物及其制备方法 | |
CN113209217A (zh) | 一种抗体力疲劳中药组合物及其制备方法 | |
CN106692667A (zh) | 一种具有降压降脂降糖功效的组合物及其用途 | |
CN111973717A (zh) | 一种具有减肥作用的紫苏子决明子组合物及制备方法 | |
CN109601880A (zh) | 一种增加骨密度的保健食品 | |
CN101143203A (zh) | 一种具有护肝养胃功能的复方口服液 | |
CN100493542C (zh) | 一种治疗血液病的中药 | |
CN102579713B (zh) | 治疗儿童肥胖症的中药及制备方法 | |
CN105687397B (zh) | 一种治疗类风湿性关节炎炎症和骨破坏的中药组合物及其用途 | |
CN100358553C (zh) | 一种具有降脂减肥作用的中药组合物及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Yule Inventor after: Liu Juntian Inventor before: Wang Yule |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WANG YULE TO: WANG YULE LIU JUNTIAN |
|
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 100062, room 11, 706 Chongwen Avenue, Dongcheng District, Beijing Patentee after: Zhongke Leren (Beijing) Technology Development Co.,Ltd. Address before: 100009, room 59, Chai Mo Hutong, 2210, Beijing, Dongcheng District Patentee before: Zhongke Leren (Beijing) Technology Development Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220829 Address after: No. 1288, Tianshan Road, Shuangyang District, Changchun City, Jilin Province, 130699 Patentee after: Changchun Luxiang Huatai Biotechnology Co.,Ltd. Address before: Room 706, No. 11, Chongwenmenwai Street, Dongcheng District, Beijing 100062 Patentee before: Zhongke Leren (Beijing) Technology Development Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221028 Address after: 201799 1121-1, No. 26, Lane 1289, Gongyuan East Road, Qingpu District, Shanghai Patentee after: Shanghai Jianxiaoda Biotechnology Co.,Ltd. Address before: No. 1288, Tianshan Road, Shuangyang District, Changchun City, Jilin Province, 130699 Patentee before: Changchun Luxiang Huatai Biotechnology Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20240107 Address after: Building D6, 2nd Floor, No. 6 Dongsheng West Road, Jiangyin City, Wuxi City, Jiangsu Province, 214400 Patentee after: Jiangsu Yingyangxing Biotechnology Co.,Ltd. Address before: 201799 1121-1, No. 26, Lane 1289, Gongyuan East Road, Qingpu District, Shanghai Patentee before: Shanghai Jianxiaoda Biotechnology Co.,Ltd. |
|
TR01 | Transfer of patent right |